"Our
research team believes that the cancer itself is not the key problem.
All of us may have hundreds of cancers in our lifetime, but our
immune system recognizes these abnormalities and removes them
before they can develop into disease. The problem is when our
immune system is unable to recognize the cancer cells and is therefore
unable to combat the tumor. When heat shock proteins are combined
with protein antigens from a specific tumor, this enables the
body*s immune system to recognize the type of cancer cells and
elicit an appropriate immune response,* said Pope Moseley, M.D.,
chief of the UNM School of Medicine*s Pulmonary, Allergy and Critical
Care Division, within the Department of Internal Medicine. UNM
researchers devised a simple, one-step method to purify the HSP-tumor
antigen protein complex. The tumor-specific vaccine is synthesized
by purifying the HSP-containing fraction of tumor cells which
are limited to the tumor antigens. The protein complex that is
produced, then has the ability to trigger the desired tumor immune
response. UNM is currently seeking to license this technology.
"There
has been a phenomenal explosion in heat shock protein research.
Cancer immunotherapy is one of the exciting new areas in cancer
research.This technology is suitable for kit applications, making
it possible for any hospital or other setting to conveniently
generate vaccines that naturally occur in a certain type of tissue
or in a specific structure of the body," said Erik Wallen,
M.S., senior research assistant at the UNM School of Medicine.
This
article has been adapted from a news release issued by University
Of New Mexico, www.unm.edu.
Next - Back
to Immune System Boosting Research